Last reviewed · How we verify
Chinese Herbal Medication
Chinese herbal medication is used to modulate the immune system and reduce inflammation.
Chinese herbal medication is used to modulate the immune system and reduce inflammation. Used for Ulcerative colitis.
At a glance
| Generic name | Chinese Herbal Medication |
|---|---|
| Also known as | E-B-FAHF-2 |
| Sponsor | Xiu-Min Li |
| Drug class | Immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism of action is not fully understood, but it is believed to work by modulating the immune system and reducing inflammation through the use of various herbal compounds. This can lead to a reduction in symptoms associated with autoimmune diseases.
Approved indications
- Ulcerative colitis
Common side effects
- Abdominal pain
- Diarrhea
- Nausea
Key clinical trials
- Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences (NA)
- Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients (PHASE2)
- Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients. (PHASE2)
- FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis (PHASE4)
- Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease (NA)
- Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients (NA)
- Integrated Chinese and Western Therapy for Cancer-Related Fatigue (NA)
- The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chinese Herbal Medication CI brief — competitive landscape report
- Chinese Herbal Medication updates RSS · CI watch RSS
- Xiu-Min Li portfolio CI